Noel Courage

Bereskin & Parr LLP

Legal Influencer

Q2| 2022

Legal Influencers

Lexology’s Legal Influencers programme recognises firms and authors that provide excellent content within a work area and region. Find out more


Results 1 to 5 of 158

Is this Drug Safe and Effective Enough? Canadian Regulators Wade into Alzheimer’s Drug Controversy

Canada - August 26 2022 Health Canada has now completed its initial review of the Biogen Alzheimer's Disease (AD) drug Aduhelm (aducanumab). Following the receipt of the…

Iris Cheung

One person’s trash is another person’s treasure - Where France goes, will others follow?

Canada, European Union, France - June 27 2022 In Part III of our series on the right to repair, we examined the European Union's regulatory initiatives to support the right to repair. Some…

Luca Manfredi

What’s it Worth? Valuation of IP

Canada - May 5 2022 The value of IP is a common topic of discussion at start-up companies. Founders may be trying to value their company for investment or sale purposes…

Canada Drops its Most Controversial Patented Drug Pricing Amendments

Canada - April 22 2022 After almost two years of suspense for pharma industry stakeholders, the Government of Canada will proceed with the implementation of some, but not…

Nyrie Israelian

Supreme Court of Canada Takes a Pass on Patented Drug Price Dispute

Canada - April 1 2022 By: Nyrie Israelian and Noel Courage The Supreme Court of Canada dismissed the Canadian Patented Medicines Prices Review Board’s (PMPRB) request for…

Nyrie Israelian